PK
T}X
Table_1.xlsUT ffࡱ >
\ p None B a = c @ = Z ?N*8 X" 1 Arial1 Arial1 Arial1 Arial1 Arial1 Arial1 Arial General ` Table_1 >D @ Healthy controls CHB patients ACLF patients N 33 47 91 Age (years) 38 (20–58) 35 (18–73) 45.5 (16–77) Gender (male:female) 13:20 35:12 68:23 ALT (U/L) 18 (8–40) 53.3 (8.7–1095.3) 73.6 (12–1188) AST (U/L) 21.0 (18.0–28.0) 49.8 (16.6–432.9) 90.65 (8–1192) TBIL (μmol/L) 11.1 (4.0–16.0) 19.1 (8.0–753.9) 355.25 (13–965) ALB (g/L) 42.1 (40.5–45.3) 38.2 (34.2–41.4) 32.8 (19–47) PALB (mg/L) – 117.4 (66.2–168.0) 65.7 (26–212) CHE (U/L) 5845.0 (1539–13100) 3996.5 (975–8930)
TBA (μmol/L) 15.5 (1–276.3) 161.7 (93.6–229.2) CREA (μmol/L) 62.0 (47.0–93.0) 68.1 (1.32–95.7) 65.1 (23–263) BUN (mmol/L) 4.84 (3.26–46.80) 3.94 (2.03–40.40)
5.11 (1–39) PTA (%) 95.5 (94–99.8) 91.4 (9.27–116.2) 35.3 (16.5–38.6) INR 0.99 (0.84–1.34) 1.60 (1–4) MELD 4.98 (–5.49–35.30) 20.5 (14.8–64.8) Regucalcin (ng/mL) 1.72 (1.44–2.39) 3.76 (2.78–5.59) 5.46 (4.32–6.58)
d MbP?_ % * + &P &F